Share
The global Poultry Biological Products And Poultry Vaccines Market was valued at approximately USD 3.5 billion in 2025 and is projected to reach USD 6.7 billion by 2035, growing at a CAGR of 6.3% during the forecast period. The market encompasses the development, production, and distribution of biological products and vaccines specifically designed for poultry health management. Key products include vaccines for diseases such as Newcastle disease, Avian Influenza, and Marekβs disease, alongside live and inactivated vaccines, recombinants, and toxoids. This market plays a crucial role in animal health strategies, ensuring productivity and sustainability in the poultry industry.
The industry has evolved substantially with advancements in biotechnology and genetic engineering, repositioning poultry health management to address emerging zoonotic diseases and antibiotic resistance. The market, now transitioning from maturation to growth, underscores strategic importance for nations focusing on food security and agricultural GDP contribution. Recent trends highlight efforts towards vaccine innovation to enhance efficacy, cost-competitiveness, and compliance with stringent regulations.
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from
